Singh Gurdev Dave 13D and 13G filings for Vivos Therapeutics, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
2022-02-14 5:02 pm Purchase | 2021-12-31 | 13G | Vivos Therapeutics, Inc. VVOS | Singh Gurdev Dave | 129,988 14.100% | 1,200 (+0.93%) | Filing |
2021-02-16 2:34 pm Purchase | 2020-12-31 | 13G | Vivos Therapeutics, Inc. VVOS | Singh Gurdev Dave | 128,788 17.700% | 128,788 (New Position) | Filing |